TipRanks tools are all you need to make data-driven investment decisions. Conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts, with ease.
The Johnson & Johnson stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
Johnson & Johnson provides healthcare products across three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
What was Johnson & Johnson’s price range in the past 12 months?
Johnson & Johnson lowest stock price was $133.65 and its highest was $179.92 in the past 12 months.
What is Johnson & Johnson’s market cap?
Johnson & Johnson’s market cap is $431.73B.
What is Johnson & Johnson’s price target?
The average price target for Johnson & Johnson is $190.50. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $200.00 ,the lowest forecast is $183.00. The average price target represents 16.16% Increase from the current price of $164.
What do analysts say about Johnson & Johnson?
Johnson & Johnson’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 7 Wall Streets Analysts.
When is Johnson & Johnson’s upcoming earnings report date?
Johnson & Johnson’s upcoming earnings report date is Oct 19, 2021 which is in 21 days.
How were Johnson & Johnson’s earnings last quarter?
Johnson & Johnson released its earnings results on Jul 21, 2021. The company reported $2.35 earnings per share for the quarter, beating the consensus estimate of $2.291 by $0.059.
Is Johnson & Johnson overvalued?
According to Wall Street analysts Johnson & Johnson’s price is currently Undervalued.
Does Johnson & Johnson pay dividends?
Johnson & Johnson pays a Quarterly dividend of $1.06 which represents an annual dividend yield of 2.52%. Johnson & Johnson’s last Quarterly dividend payment was on Sep 07, 2021. Johnson & Johnson’s upcoming ex-dividend date is Aug 23, 2021
What is Johnson & Johnson’s EPS estimate?
Johnson & Johnson’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Johnson & Johnson have?
Johnson & Johnson has 2,630,000,000 shares outstanding.
What happened to Johnson & Johnson’s price movement after its last earnings report?
Johnson & Johnson reported an EPS of $2.35 in its last earnings report, beating expectations of $2.291. Following the earnings report the stock price went up 0.914%.
Which hedge fund is a major shareholder of Johnson & Johnson?
Among the largest hedge funds holding Johnson & Johnson’s share is Bridgewater Associates, LP. It holds Johnson & Johnson’s shares valued at 465M.